Top

Published in:

Open Access 01-02-2019 | Letter to the Editor

A case report of TAFRO syndrome successfully treated by immunosuppressive therapies with plasma exchange

Authors: Yusuke Meguri, Noboru Asada, Yukio Nakasako, Eisei Kondo, Yui Kambara, Akira Yamamoto, Taro Masunari, Nobuo Sezaki, Genyo Ikeda, Tomohiro Toji, Tadashi Yoshino, Toru Kiguchi

Published in: Annals of Hematology | Issue 2/2019

Excerpt

Dear Editor, …

Masaki Y, Nakajima A, Iwao H, Kurose N, Sato T, Nakamura T, Miki M, Sakai T, Kawanami T, Sawaki T, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Umehara H (2013) Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman-Kojima disease) a distinct clinicopathological entity? J Clin Exp Hematop 53:79–85CrossRefPubMed

Iwaki N, Fajgenbaum DC, Nabel CS, Gion Y, Kondo E, Kawano M, Masunari T, Yoshida I, Moro H, Nikkuni K, Takai K, Matsue K, Kurosawa M, Hagihara M, Saito A, Okamoto M, Yokota K, Hiraiwa S, Nakamura N, Nakao S, Yoshino T, Sato Y (2016) Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol 91:220–226CrossRefPubMed

Yamaga Y, Tokuyama K, Kato T, Yamada R, Murayama M, Ikeda T, Yamakita N, Kunieda T (2016) Successful treatment with cyclosporin A in tocilizumab-resistant TAFRO syndrome. Intern Med 55:185–190CrossRefPubMed

Sakashita K, Murata K, Takamori M (2018) TAFRO syndrome: current perspectives. J Blood Med 9:15–23CrossRefPubMedPubMedCentral

Nagano M, Matsumoto J (2016) A case of TAFRO syndrome with a large mediastinal mass treated with debulking surgery. Surg Case Rep 2:61CrossRefPubMedPubMedCentral

Nakae H, Asanuma Y, Tajimi K (2002) Cytokine removal by plasma exchange with continuous hemodiafiltration in critically ill patients. Ther Apher 6:419–424CrossRefPubMed

Fujimaru T, Ito S, Masuda H, Oana S, Kamei K, Ishiguro A, Kato H, Abe J (2014) Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange. Cytokine 70:156–160CrossRefPubMed

Shariatmadar S, Nassiri M, Vincek V (2005) Effect of plasma exchange on cytokines measured by multianalyte bead array in thrombotic thrombocytopenic purpura. Am J Hematol 79:83–88CrossRefPubMed

Sadeghi M, Daniel V, Wang H, Zeier M, Schemmer P, Mehrabi A, Lahdou I, Morath C, Opelz G (2013) Plasmapheresis adjusts inflammatory responses in potential kidney transplant recipients. Transplantation 95:1021–1029CrossRefPubMed

10.

Iwaki N, Gion Y, Kondo E, Kawano M, Masunari T, Moro H, Nikkuni K, Takai K, Hagihara M, Hashimoto Y, Yokota K, Okamoto M, Nakao S, Yoshino T, Sato Y (2017) Elevated serum interferon gamma-induced protein 10 kDa is associated with TAFRO syndrome. Sci Rep 7:42316CrossRefPubMedPubMedCentral

Title: A case report of TAFRO syndrome successfully treated by immunosuppressive therapies with plasma exchange
Authors: Yusuke Meguri
Noboru Asada
Yukio Nakasako
Eisei Kondo
Yui Kambara
Akira Yamamoto
Taro Masunari
Nobuo Sezaki
Genyo Ikeda
Tomohiro Toji
Tadashi Yoshino
Toru Kiguchi
Publication date: 01-02-2019
Publisher: Springer Berlin Heidelberg
Published in: Annals of Hematology / Issue 2/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-018-3456-9

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A case report of TAFRO syndrome successfully treated by immunosuppressive therapies with plasma exchange

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2019

Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)

Low extracellular vesicle–associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosis

Comparative assessment of prognostic models in chronic lymphocytic leukemia: evaluation in Indian cohort

Platelet number and graft function predict intensive care survival in allogeneic stem cell transplantation patients

Autoimmune disease-associated non-Hodgkin’s lymphoma—a large retrospective study from China

Utility of allogeneic hematopoietic stem cell transplantation using international donors in a homogenous ethnic population: question in the era of various alternative donors

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page